We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...
Alvotech (NASDAQ:ALVO) and Teva Pharmaceuticals (NYSE:TEVA) said on Tuesday that the U.S. FDA has accepted for review a ...
Silo currently has patents issued and numerous expanded patent applications pending for SPC-15, a technology that was ...
CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...
India - Proceedings Seeking Revocation Of A Patent Not Same As Those Seeking A Finding Of Invalidity. Legal News and Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results